Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for HUMA

Stock NameHumacyte Inc
TickerHUMA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS44486Q1031

Show aggregate HUMA holdings

News associated with HUMA

D. Boral Capital Reaffirms “Buy” Rating for Humacyte (NASDAQ:HUMA)
Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reissued by analysts at D. Boral Capital in a note issued to investors on Monday,Benzinga reports. They currently have a $25.00 price target on the stock. Other equities analysts have also issued research reports about the company. Barclays assumed coverage on Humacyte in a […] - 2025-09-17 03:00:48
Brokerages Set Humacyte, Inc. (NASDAQ:HUMA) Target Price at $10.64
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) has received an average rating of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. […] - 2025-08-29 03:04:48
Humacyte (NASDAQ:HUMA) Stock Rating Lowered by Wall Street Zen
Humacyte (NASDAQ:HUMA – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Sunday. HUMA has been the topic of several other reports. HC Wainwright lowered their price target on Humacyte from $4.00 to $3.00 and set a “buy” […] - 2025-08-19 02:47:01
XTX Topco Ltd Buys 9,868 Shares of Humacyte, Inc. (NASDAQ:HUMA)
XTX Topco Ltd raised its stake in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 22.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 53,797 shares of the company’s stock after buying an additional 9,868 shares during the quarter. XTX Topco Ltd’s […] - 2025-08-15 04:30:58
Humacyte (NASDAQ:HUMA) Earns “Buy” Rating from D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report issued on Monday,Benzinga reports. The firm currently has a $25.00 target price on the stock. HUMA has been the subject of several other research reports. Benchmark reduced their target price on shares of Humacyte from $17.00 to […] - 2025-08-14 02:27:14
Pre-Market Most Active for Jul 31, 2025 : INDV, TSLL, NVDA, SQQQ, APLD, HUMA, NVO, MUFG, NIO, NCLH, BBAI, RBLX
The NASDAQ 100 Pre-Market Indicator is up 326.17 to 23,671.58. The total Pre-Market volume is currently 138,935,572 shares traded.The following are the most active stocks for the pre-market session: Indivior PLC (INDV) is +1.9 at $19.30, with 13,246,867 shares traded. INDV's cur - 2025-07-31 09:28:54
Humacyte (NASDAQ:HUMA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Humacyte (NASDAQ:HUMA – Free Report) from a hold rating to a sell rating in a report released on Friday. A number of other research firms have also recently issued reports on HUMA. Benchmark decreased their target price on Humacyte from $17.00 to $14.00 and set a “buy” rating for […] - 2025-07-21 02:48:50
Analysts Set Humacyte, Inc. (NASDAQ:HUMA) Target Price at $11.71
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating on the […] - 2025-07-10 02:34:52
Beat the Market the Zacks Way: Humacyte, Starbucks, Oracle in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months. - 2025-07-07 10:08:00
Humacyte, Inc. (NASDAQ:HUMA) Given Consensus Rating of “Buy” by Analysts
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy […] - 2025-06-12 04:56:56
Squarepoint Ops LLC Invests $132,000 in Humacyte, Inc. (NASDAQ:HUMA)
Squarepoint Ops LLC bought a new position in Humacyte, Inc. (NASDAQ:HUMA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 26,098 shares of the company’s stock, valued at approximately $132,000. Other hedge funds and other institutional investors have also recently modified […] - 2025-06-10 04:26:51
Humacyte, Inc. (NASDAQ:HUMA) Stock Position Raised by ProShare Advisors LLC
ProShare Advisors LLC lifted its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 30.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,852 shares of the company’s stock after acquiring an additional 7,188 shares during the […] - 2025-06-02 05:34:50
Humacyte (NASDAQ:HUMA) versus ProKidney (NASDAQ:PROK) Financial Comparison
Humacyte (NASDAQ:HUMA – Get Free Report) and ProKidney (NASDAQ:PROK – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Analyst Recommendations This is a summary of current recommendations […] - 2025-05-30 03:08:50
Humacyte, Inc. (NASDAQ:HUMA) Holdings Decreased by Two Sigma Investments LP
Two Sigma Investments LP reduced its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 14.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 919,097 shares of the company’s stock after selling 149,142 shares during the quarter. Two […] - 2025-05-28 05:04:50
Humacyte, Inc. (NASDAQ:HUMA) Receives $11.71 Consensus Price Target from Brokerages
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating […] - 2025-05-21 02:06:53
HC Wainwright Initiates Coverage on Humacyte (NASDAQ:HUMA)
HC Wainwright started coverage on shares of Humacyte (NASDAQ:HUMA – Get Free Report) in a research note issued on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $4.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 111.64% from the stock’s current price. A number of […] - 2025-05-16 05:46:53
Humacyte, Inc. (NASDAQ:HUMA) Holdings Lowered by Marshall Wace LLP
Marshall Wace LLP decreased its stake in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 90.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 54,917 shares of the company’s stock after selling 529,645 shares during the quarter. Marshall Wace LLP’s holdings in Humacyte were worth […] - 2025-05-05 05:37:01
Legal & General Group Plc Acquires 13,293 Shares of Humacyte, Inc. (NASDAQ:HUMA)
Legal & General Group Plc raised its stake in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 19.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 81,405 shares of the company’s stock after buying an additional 13,293 shares during the quarter. Legal […] - 2025-04-30 04:54:52
XTX Topco Ltd Increases Position in Humacyte, Inc. (NASDAQ:HUMA)
XTX Topco Ltd boosted its holdings in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 29.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,929 shares of the company’s stock after purchasing an additional 9,880 shares during the quarter. XTX Topco Ltd’s holdings in Humacyte […] - 2025-04-28 05:11:10
Charles Schwab Investment Management Inc. Boosts Holdings in Humacyte, Inc. (NASDAQ:HUMA)
Charles Schwab Investment Management Inc. increased its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 7.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 775,718 shares of the company’s stock after purchasing an additional 54,400 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Humacyte were worth $3,917,000 […] - 2025-03-27 05:13:09
Intech Investment Management LLC Has $304,000 Position in Humacyte, Inc. (NASDAQ:HUMA)
Intech Investment Management LLC grew its position in Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 41.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,178 shares of the company’s stock after acquiring an additional 17,563 shares during the period. […] - 2025-03-26 06:23:10
Humacyte (NASDAQ:HUMA) Given Buy Rating at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research report report published on Friday,Benzinga reports. They currently have a $25.00 target price on the stock. Several other analysts have also recently commented on the stock. Benchmark reaffirmed a “buy” rating on shares of Humacyte in a […] - 2025-03-10 03:37:45
Short Interest in Humacyte, Inc. (NASDAQ:HUMA) Drops By 6.2%
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 24,040,000 shares, a drop of 6.2% from the January 15th total of 25,640,000 shares. Based on an average daily volume of 4,330,000 shares, the short-interest ratio is […] - 2025-02-19 06:42:38
Humacyte, Inc. (NASDAQ:HUMA) Receives $13.71 Consensus Price Target from Analysts
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) has received a consensus rating of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-02-14 06:22:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) HUMA holdings

DateNumber of HUMA Shares HeldBase Market Value of HUMA SharesLocal Market Value of HUMA SharesChange in HUMA Shares HeldChange in HUMA Base ValueCurrent Price per HUMA Share HeldPrevious Price per HUMA Share Held
2025-11-11 (Tuesday)104,529USD 133,797HUMA holding decreased by -7317USD 133,7970USD -7,317 USD 1.28 USD 1.35
2025-11-10 (Monday)104,529HUMA holding increased by 280USD 141,114HUMA holding increased by 2463USD 141,114280USD 2,463 USD 1.35 USD 1.33
2025-11-07 (Friday)104,249USD 138,651HUMA holding increased by 2085USD 138,6510USD 2,085 USD 1.33 USD 1.31
2025-11-06 (Thursday)104,249HUMA holding increased by 279USD 136,566HUMA holding decreased by -14191USD 136,566279USD -14,191 USD 1.31 USD 1.45
2025-11-05 (Wednesday)103,970USD 150,757HUMA holding decreased by -1039USD 150,7570USD -1,039 USD 1.45 USD 1.46
2025-11-04 (Tuesday)103,970HUMA holding increased by 280USD 151,796HUMA holding decreased by -13071USD 151,796280USD -13,071 USD 1.46 USD 1.59
2025-11-03 (Monday)103,690USD 164,867HUMA holding decreased by -8295USD 164,8670USD -8,295 USD 1.59 USD 1.67
2025-10-31 (Friday)103,690USD 173,162HUMA holding increased by 5184USD 173,1620USD 5,184 USD 1.67 USD 1.62
2025-10-30 (Thursday)103,690HUMA holding increased by 1400USD 167,978HUMA holding decreased by -4892USD 167,9781,400USD -4,892 USD 1.62 USD 1.69
2025-10-29 (Wednesday)102,290HUMA holding increased by 560USD 172,870HUMA holding decreased by -71USD 172,870560USD -71 USD 1.69 USD 1.7
2025-10-28 (Tuesday)101,730USD 172,941HUMA holding increased by 2035USD 172,9410USD 2,035 USD 1.7 USD 1.68
2025-10-27 (Monday)101,730USD 170,906HUMA holding decreased by -3052USD 170,9060USD -3,052 USD 1.68 USD 1.71
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HUMA by Blackrock for IE00BYXG2H39

Show aggregate share trades of HUMA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY2801.4201.320 1.330USD 372 2.84
2025-11-06BUY2791.4601.260 1.280USD 357 2.86
2025-11-04BUY2801.5581.460 1.470USD 412 2.87
2025-10-30BUY1,4001.7001.600 1.610USD 2,254 2.89
2025-10-29BUY5601.6901.780 1.771USD 992 2.90
2025-10-22SELL-1,1001.6201.750 1.737USD -1,911 2.93 Profit of 1,313 on sale
2025-10-20BUY5501.8101.895 1.886USD 1,038 2.94
2025-10-17BUY1,3711.7201.750 1.747USD 2,395 2.95
2025-10-15BUY2,1681.7701.820 1.815USD 3,935 2.96
2025-10-03BUY1,9602.1002.220 2.208USD 4,328 2.97
2025-10-02BUY2801.7901.790 1.790USD 501 2.97
2025-09-30BUY5601.7401.780 1.776USD 995 2.99
2025-09-26BUY5601.7301.740 1.739USD 974 3.00
2025-09-25BUY5601.6101.670 1.664USD 932 3.01
2025-09-24BUY11.6801.820 1.806USD 2 3.02
2025-09-18BUY2791.7901.880 1.871USD 522 3.03
2025-09-17BUY8401.5301.620 1.611USD 1,353 3.03
2025-08-20SELL-1,1161.6301.690 1.684USD -1,879 3.07 Profit of 1,546 on sale
2025-07-30BUY1,0842.4302.455 2.452USD 2,659 3.11
2025-07-17SELL-5442.4202.460 2.456USD -1,336 3.15 Profit of 377 on sale
2025-07-11SELL-2,2002.3102.500 2.481USD -5,458 3.17 Profit of 1,517 on sale
2025-07-07BUY8252.1602.300 2.286USD 1,886 3.19
2025-07-02BUY15,1252.3102.380 2.373USD 35,892 3.20
2025-06-20BUY18,0232.3102.400 2.391USD 43,093 3.21
2025-06-11BUY4262.5402.710 2.693USD 1,147 3.25
2025-06-10BUY4262.6702.790 2.778USD 1,183 3.26
2025-06-04SELL-2132.6302.870 2.846USD -606 3.28 Profit of 92 on sale
2025-04-23BUY2131.4701.540 1.533USD 327 3.70
2025-04-10SELL-1,7041.5701.600 1.597USD -2,721 3.92 Profit of 3,956 on sale
2025-04-08SELL-2131.1501.350 1.330USD -283 3.98 Profit of 564 on sale
2025-04-07SELL-2131.2601.320 1.314USD -280 4.01 Profit of 574 on sale
2025-04-04SELL-1,0651.3501.420 1.413USD -1,505 4.04 Profit of 2,799 on sale
2025-04-01BUY8521.4901.730 1.706USD 1,454 4.10
2025-03-31SELL-6391.7051.900 1.880USD -1,202 4.13 Profit of 1,439 on sale
2025-03-14SELL-3,4243.0403.080 3.076USD -10,532 4.33 Profit of 4,306 on sale
2025-03-07SELL-4283.0903.110 3.108USD -1,330 4.44 Profit of 569 on sale
2025-03-04SELL-2143.2003.300 3.290USD -704 4.50 Profit of 259 on sale
2025-02-25BUY4283.0403.300 3.274USD 1,401 4.61
2025-02-19SELL-2133.8703.890 3.888USD -828 4.68 Profit of 170 on sale
2025-02-13BUY6333.9204.040 4.028USD 2,550 4.75
2025-02-12BUY2113.9604.110 4.095USD 864 4.77
2025-02-11BUY8444.0104.080 4.073USD 3,438 4.78
2024-12-30SELL-1,0705.0905.470 5.432USD -5,812 4.89 Loss of -576 on sale
2024-11-18SELL-3,1234.4454.840 4.801USD -14,992 5.40 Profit of 1,872 on sale
2024-11-08SELL-2085.7806.110 6.077USD -1,264 5.38 Loss of -146 on sale
2024-10-21SELL-2115.3405.359 5.357USD -1,130 0.00 Loss of -1,130 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HUMA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,553,73721,7942,595,20959.9%
2025-09-182,881,87720,2065,416,74953.2%
2025-09-17414,907690889,63846.6%
2025-09-16807,6231,3851,536,27952.6%
2025-09-15689,34301,227,05256.2%
2025-09-12354,6090586,43560.5%
2025-09-11714,5574711,167,43461.2%
2025-09-10586,353150968,84260.5%
2025-09-09599,0757701,166,80251.3%
2025-09-08581,7668,245927,73562.7%
2025-09-05985,8389,9941,573,04062.7%
2025-09-04503,1220964,46452.2%
2025-09-031,169,37801,497,89378.1%
2025-09-02651,3241,8081,097,36659.4%
2025-08-29768,1091,6431,128,55768.1%
2025-08-281,228,83601,893,01164.9%
2025-08-27975,3116001,957,63049.8%
2025-08-261,101,75020,3991,894,48958.2%
2025-08-25598,40714,9001,130,82352.9%
2025-08-22946,55632,1591,911,22949.5%
2025-08-211,555,57621,7112,465,71363.1%
2025-08-201,901,755381,3933,094,25961.5%
2025-08-194,246,247609,6115,141,19682.6%
2025-08-181,308,681159,9131,807,19272.4%
2025-08-151,751,1122002,766,09963.3%
2025-08-142,259,028863,964,26457.0%
2025-08-131,736,4453,2073,077,81856.4%
2025-08-122,363,260174,7364,165,05656.7%
2025-08-1112,640,5101,124,21616,597,61276.2%
2025-08-084,020,68854,9326,113,62565.8%
2025-08-07736,6891,4031,779,67441.4%
2025-08-061,218,1544,5372,033,68159.9%
2025-08-05605,0457711,342,73645.1%
2025-08-04702,58424,2111,362,96451.5%
2025-08-011,019,27639,1351,848,45755.1%
2025-07-31962,9233,3911,568,54261.4%
2025-07-30932,8151,8111,314,75570.9%
2025-07-29788,9587,5481,493,39252.8%
2025-07-281,208,2788,4861,827,95166.1%
2025-07-251,359,3369012,058,36266.0%
2025-07-24897,5824,6722,211,68740.6%
2025-07-232,872,86799,9986,398,04244.9%
2025-07-22423,3246,9681,742,22224.3%
2025-07-21755,9124,1311,126,72767.1%
2025-07-18477,882466802,88159.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.